We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA helps Achilles Therapeutics treat non-small cell lung cancer through innovation.
Pioneering treatment for multiple myeloma - partially-funded by an Innovate UK grant - reaches clinical stage.
Employment Tribunal decision.
New guidance on contraceptive methods and frequency of pregnancy testing to reduce inadvertent exposures during pregnancy in a woman taking a medicine of teratogenic potential.
Employment Appeal Tribunal judgment of Mr Justice Cavanagh on 1 April 2021.
Men who inject anabolic steroids and tanning drugs are at higher risk of HIV and viral hepatitis.
A year on from its Women’s Health Strategy, the government has announced a package of new measures to boost the health and wellbeing of women and girls.
First published during the 2022 to 2024 Sunak Conservative government
TCR2 Therapeutics will become the first international organisation to work with the Cell and Gene Therapy Catapult manufacturing centre.
Caution should be used in patients with known risk factors for venous thromboembolism in addition to the underlying disease. Patients older than 65 years of age are at an increased risk of serious infections and should be treated with tofacitinib...
The strategic outline case and accompanying value for money addendum
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Cell and Gene Therapy Catapult announces £3 million funding to advance life sciences through skills and apprenticeships, as part of the Industrial Strategy.
Employment Appeal Tribunal judgment of Judge Tucker on 06 October 2020.
Drug interactions involving CYP2D6, genetic variants, and variability in clinical response
First published during the 2019 to 2022 Johnson Conservative government
Sildenafil is not authorised for use in pregnancy for the treatment of intrauterine growth restriction. The STRIDER clinical trial, which was studying the use of sildenafil in pregnancy for intrauterine growth restriction, has been prematurely discontinued due to a higher...
A new study by Public Health England, the University of Oxford and others reveals we can better predict a patient’s response to TB treatments.
Patients trust in a trial of acyclovir genital herpes treatment has been shown to be crucial to its success
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).